(Q34227152)

31 July 2017

1 reference

title

Lipid-lowering drugs in lupus: an unexplored therapeutic intervention (English)

1 reference

31 July 2017

A S Wierzbicki

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

233-236

1 reference

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Effects of anti-CD4 antibodies on the release of IL-6 and TNF-alpha in whole blood samples from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Protein prenylation: molecular mechanisms and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

C-reactive protein, inflammation, and coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Regulation of lipid and lipoprotein metabolism by PPAR activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Peroxisome proliferator-activated receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Effects of lovastatin on natural killer cell function and other immunological parameters in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Assessment and treatment of endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F096120301666117984

10.1191/096120301666117984

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference